There is clear precedent for a role of signal transduction pathways in
modification of the renal sodium pump. Agonists regulate the pump eit
her by changing abundance of subunits, usually chronic processes, or b
y altering existing transporters. Despite strong evidence from in vitr
o observations, these mechanisms play an unclear role in the intact an
imal. Particularly in the proximal nephron of the kidney, where the ra
te of activity is high, in vivo regulation of the sodium pump is not w
ell understood. In animal models of hypertension, Na,K-ATPase in the k
idney displays an abnormal response to exogenous mineralocorticoid, in
fused angiotensin II, or to application of catecholamines, suggesting
the important influence of intracellular signaling pathways and recept
ors. It is not surprising that hormones and their receptors initiate a
variety of discrete intracellular pathways to control activity of Na,
K-ATPase. Intracellular sites that are documented to be employed in ho
rmonal regulation include direct and indirect effects on isoform trans
cription, modification of isoform half-life, and posttranslational mod
ification. Future investigation will clarify the precise molecular mec
hanisms that occur at these intracellular sites.